Nucleate Boston

🌟 Ready to build your career in early-stage biotech venture and entrepreneurship? Join Nucleate and a lineup of bio+tech investors and talent scouts on August 1st at 3pm to learn how to set yourself up for success. This virtual panel is designed for trainees excited to pursue careers in biotech startups and venture capital (VC). The interactive panel will feature four esteemed professionals who will share insights into their career paths, the types of roles available, and the key experiences needed to break into this rapidly-expanding field. 🔗 Register here to secure your spot: https://lu.ma/y795l12s 🎤 The panel features: Eric Dai - Investor, Dimension Natalie Estrella - Talent Partner, Cantos Rahil Haneef - Principal & Senior VP, LifeSci Search & LifeSci Partners Yusuf Uddin, PhD - Head of Talent, KdT Ventures Susanna Harris, PhD (moderator) - Director of Community, Breakout Ventures

We are thrilled to announce that MilliporeSigma has renewed its sponsorship of Nucleate with a three-year commitment! This partnership significantly bolsters support for early-stage biotech companies emerging from Nucleate’s Activator program. Over the past five years, our Activator program has empowered 411 teams, helping them raise over $387 million and create more than 233 jobs. MilliporeSigma's renewed support underscores their dedication to nurturing the next generation of biotech innovators. MilliporeSigma’s experts will offer mentorship and valuable insights, enhancing our ventures' potential for innovation and growth. This collaboration is crucial for developing early-stage biotech talent and transforming groundbreaking ideas into impactful solutions. For more information about this partnership and opportunities for early-stage biotech companies, visit https://lnkd.in/geABJh-X.

We are thrilled to announce a gold-tier partnership between Nucleate Boston and Banc of California. Banc of California will be the exclusive banking sponsor of the Boston chapter of Nucleate for our 2024 Activator Innovators. Standing at the forefront of bespoke banking and treasury management, Banc of California provides services to small-, middle-market, and venture-backed businesses. With a deep understanding of the unique challenges and opportunities within the VC and PE landscapes, they are uniquely poised to support Nucleate's Activator teams. Their Venture Banking Group offers an extensive array of services including venture debt, fund finance, and comprehensive treasury management solutions, catering to key groups such as VC-backed multi-stage tech companies, VC and PE fund finance, emerging life science companies, and more. As the exclusive banking sponsor for 2023-2024, Banc of California's expertise and tailored financial services will serve our talented Activator innovators, further bolstering Boston's vibrant biotech ecosystem. We express our deepest gratitude to Banc of California for believing in our vision and for their invaluable support. Together, we look forward to paving the way for the next wave of innovations and democratizing biotechnology.

Big shoutout to the four GRID-advised teams that recently pitched at the Nucleate Boston Activator Demo Day! These innovative projects are pushing the boundaries of healthcare technology... Karyo: A catheter-based device enabling early detection of pre-cancerous biomarkers in the fallopian tubes to screen for and prevent ovarian cancer. Team: Allie Stasior, Chris Grimestad, Ricky Cordova RhinUS: A minimally invasive device designed to combat biofilms and treat chronic rhinosinusitis. Team: Alec Creta, Ana Trapero Martín Four-Forty: Revolutionizing skin visualization for both patients and physicians. Team: Anthony Mei, Yuxiao (Michelle) Wei Lybra Bio.: Non-invasive microneedle technology to restore skin equilibrium in severe autoimmune diseases. Team: Núria Puigmal Domínguez, Samar Shanazarov Congratulations to all teams for their groundbreaking work and presentations! #venturingatharvard #harvardgrid #Nucleate #toughtech #innovation

Lamprna Therapeutics is shining a new light on better RNA silencing! We are thrilled to share that Lamprna Team has become a finalist at the Nucleate Demo Day! Participating in the #Nucleate Activator Program has been an incredible journey. Special thanks to our mentors, Emiliano Cló and Mathias Cousin, for their invaluable guidance and expertise. We're also grateful to the #Harvard Biotech Club Incubator Program for providing indispensable insights from advisors that have propelled our RNA therapeutics technology forward. We're committed to advancing our RNA technology and building our program, continuing our work in this innovative field with your help. Photo credit: # Damon (Feng) Wang, PhD

Our regional Nucleate Demo Days have showcased a diverse array of technologies from our Activator teams. Here is a peak at some of the technologies showcased at the Nucleate Boston event! 👏 🚀 Nucleate's flagship Activator program helps trainees transform cutting-edge research into viable biotech ventures, tackling critical challenges in human and planetary health. With over 411 teams from 41 chapters across 24 countries, Nucleate has grown into the largest trainee-led global biotech accelerator 🚀 Let us know in the comments which technologies you are excited about! 💫 ⭐ Teams: RhinUS (Alec Creta, Ana Trapero Martín, Bridget Slomka) Neoclease (Chelsea Trengrove, PhD), MabLab (Skye Lam, Vienna Sparks) HealthiFY (Emre Bektik, Rajnish Jaiswal) Dotilix Pharmaceuticals (Fang Xie), Four-Forty (Yuxiao (Michelle) Wei), and KiraGen Bio (Aaron Edwards Ryan Murray, PhD)

Thank you to the Nucleate Boston Activator Program for selecting Neoclease as the recipient of the Alnylam Pharmaceuticals Regional Scientific Excellence Award. We are honored to be chosen among so many incredible new startups. At Neoclease, we merge cutting-edge scientific research with advanced AI technology to bring precision gene editing forward. Thank you for recognizing our commitment to innovation and scientific excellence! Our team will be at BIO in San Diego and we would love to meet with you! Reach out to us here or at info@neoclease.com to say hello. #NucleateActivator #AlnylamPharmaceuticals #ScientificExcellence #neoclease #PrecisionMedicine #GeneEditing #Innovation #AI

We are delighted to announce the release of our latest Hidden Layers article on Nucleate's Signal platform! "An Overview of Brazilian VC Activity in Biotech" delves into Brazil's biotech venture capital ecosystem, highlighting recent investment trends, key players, and emerging startup technologies. Authored by Romina Soledad Horianski, PhD Candidate at the University of Sao Paulo and LATAM Leader at Nucleate’s Ecosystems Research Initiative, we are thrilled to shed light on this emerging ecosystem! Don't miss out on this insightful read! Access the full article on Signal now https://lnkd.in/gxFJpYjj. Be sure to Subscribe to Nucleate Signal (https://lnkd.in/g-MrVf_v) to stay up to date with the latest Hidden Layers posts and Nucleate podcasts. #Biotech #Brazil #Innovation

We're thrilled by the incredible success of our Boston Demo Day event last Tuesday. It was a day filled with exciting tech, top notch pitches, and networking to wrap up this years Nucleate Boston Activator Program. We extend our heartfelt thanks to all who attended and made it unforgettable – we hope you enjoyed it as much as we did! After thorough deliberation, our esteemed judges, Ann DeWitt, Peter Barrett, and Mariela Jaskelioff, determined this year's awardees🌟: ✨ 🏆 Boston Activator 1st Place 🏆 ✨: KiraGen Bio 🏆 MilliporeSigma Regional High Impact Culture Award: AbscoTx 🏆 Genentech Regional Diversity, Equity, and Inclusion Prize: Four-Fourty 🏆 Alnylam Pharmaceuticals Regional Scientific Excellence Award: Neoclease 🏆 UMassM2D2 Lab Space Prize: MabLab The pitches were fantastic and every team should be exceptionally proud of their hard work throughout this Nucleate Activator cycle! We are incredibly thankful to our Semi-Finalist Judges: Iva Toudjarska, Jeff Knox, Jeff Stevens, Jennifer Griffin, Julius Knowles, Michael Fenn, Ph.D., Seo Lee, Andrew Hedin, Stacy Swider, Taewon Yoon, and Vinit Nijhawan (he/him). Thank you to our mentors, experts, and sponsors whose support made this event possible. This includes Novo Nordisk, New England Biolabs, Banc of California, Sanofi, Wyss Institute at Harvard University, and Breakout Ventures, who sponsored our Activator cycle this year. Demo Day was hosted by The Engine and supported by Excedr, EOS Bioinnovation, Biological Design Center, UMass Chan Medical School, and UMassM2D2. We also want to highlight the invaluable contributions of our HQ platinum sponsors: Eli Lilly and Company, Genentech, Pillar VC, Alnylam Pharmaceuticals, BlueYard Capital, and MilliporeSigma. Stay tuned for more updates, photos, and details about our upcoming Phase 6 Summit in August! Ticket link here: https://lnkd.in/esBbe8-5 📸 Caroline Steingard, PhD

#DemoDay is less than 1 week away! We are super excited to see what some of the brightest and budding #entrepreneurs in the #Boston #biotech #ecosystem have to offer!  We hope to see you this Tuesday, May 21st, to celebrate the culmination of our 7th Activator program with Demo day, network with the community, and #nucleate. Register today at https://lu.ma/cn3yi4lz to let us know that you'll be there.